Missense mutation and defective function of ATM in a childhood acute leukemia patient with MLL gene rearrangement

被引:33
作者
Oguchi, K
Takagi, M
Tsuchida, R
Taya, Y
Ito, E
Isoyama, K
Ishii, E
Zannini, L
Delia, D
Mizutani, S
机构
[1] Tokyo Med & Dent Univ, Postgrad Med Sch, Dept Pediat & Dev Biol, Bunkyo Ku, Tokyo 1138519, Japan
[2] Hirosaki Univ, Sch Med, Dept Pediat, Tokyo, Japan
[3] Natl Canc Ctr, Res Inst, Div Radiobiol, Tokyo 104, Japan
[4] Showa Univ, Fujigaoka Hosp, Dept Pediat, Kanagawa, Japan
[5] Saga Med Sch, Dept Pediat, Saga, Japan
[6] Ist Nazl Tumori, Dept Expt Oncol, I-20133 Milan, Italy
关键词
D O I
10.1182/blood-2002-02-0570
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The possible involvement of germline mutation of the ataxia telangiectasia mutated (ATM) gene in childhood acute leukemia with mixed lineage leukemia (MLL) gene rearrangement (MLL+) was investigated. Of the 7 patients studied, 1 showed a germline missense ATM mutation (8921C>T; Pro2974Leu), located in the phosphatidyl-inositol-3 (PI-3) kinase domain. In reconstitution assays, the ATM mutant 8921T could only partially rescue the radiosensitive phenotype of AT fibroblasts, and in an in vitro kinase assay, it showed a defective phosphorylation of p53-Ser15. Furthermore, the introduction of 8921T in U2OS cells, characterized by a normal ATM/p53 signal transductibn, caused a significant reduction of in vivo p53-Ser15 phosphorylation, suggesting a dominant-negative effect of the mutant ATM over the wild-type protein. Our finding in this patient suggests that altered function of ATM plays some pathogenic roles in the development of MLL+ leukemia. (C) 2003 by The American Society of Hematology.
引用
收藏
页码:3622 / 3627
页数:6
相关论文
共 51 条
[1]  
Alexander FE, 2001, CANCER RES, V61, P2542
[2]   Enhanced phosphorylation of p53 by ATN in response to DNA damage [J].
Banin, S ;
Moyal, L ;
Shieh, SY ;
Taya, Y ;
Anderson, CW ;
Chessa, L ;
Smorodinsky, NI ;
Prives, C ;
Reiss, Y ;
Shiloh, Y ;
Ziv, Y .
SCIENCE, 1998, 281 (5383) :1674-1677
[3]   The ataxia-telangiectasia gene product, a constitutively expressed nuclear protein that is not up-regulated following genome damage [J].
Brown, KD ;
Ziv, Y ;
Sadanandan, SN ;
Chessa, L ;
Collins, FS ;
Shiloh, Y ;
Tagle, DA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (05) :1840-1845
[4]  
Bullrich F, 1999, CANCER RES, V59, P24
[5]  
CANMAN CE, 1994, CANCER RES, V54, P5054
[6]   Activation of the ATM kinase by ionizing radiation and phosphorylation of p53 [J].
Canman, CE ;
Lim, DS ;
Cimprich, KA ;
Taya, Y ;
Tamai, K ;
Sakaguchi, K ;
Appella, E ;
Kastan, MB ;
Siliciano, JD .
SCIENCE, 1998, 281 (5383) :1677-1679
[7]   HYPERSENSITIVITY OF LYMPHOBLASTOID LINES DERIVED FROM ATAXIA-TELANGIECTASIA PATIENTS TO THE INDUCTION OF CHROMOSOMAL-ABERRATIONS BY ETOPOSIDE (VP-16) [J].
CAPOROSSI, D ;
PORFIRIO, B ;
NICOLETTI, B ;
PALITTI, F ;
DEGRASSI, F ;
DESALVIA, R ;
TANZARELLA, C .
MUTATION RESEARCH, 1993, 290 (02) :265-272
[8]   OVERPRODUCTION OF TOPOISOMERASE-II IN AN ATAXIA TELANGIECTASIA FIBROBLAST CELL-LINE - COMPARISON WITH A TOPOISOMERASE-II-OVERPRODUCING HAMSTER-CELL MUTANT [J].
DAVIES, SM ;
HARRIS, AL ;
HICKSON, ID .
NUCLEIC ACIDS RESEARCH, 1989, 17 (04) :1337-1351
[9]  
Delia D, 2000, BRIT J CANCER, V82, P1938
[10]  
Garnier J, 1996, METHOD ENZYMOL, V266, P540